Similar articles

• Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.

  Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Tunney MM, et al. Am J Respir Crit Care Med. 2013 May 15;187(10):1118-26. doi: 10.1164/rccm.201210-1937OC. Am J Respir Crit Care Med. 2013. PMID: 23348972 Free PMC article.
• Update on non-cystic fibrosis bronchiectasis.

  Bilton D. Bilton D. Curr Opin Pulm Med. 2008 Nov;14(6):595-9. doi: 10.1097/MCP.0b013e328312ed8c. Curr Opin Pulm Med. 2008. PMID: 18812838 Review.
• Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.

  Bilton D, Henig N, Morrissey B, Gotfried M. Bilton D, et al. Chest. 2006 Nov;130(5):1503-10. doi: 10.1378/chest.130.5.1503. Chest. 2006. PMID: 17099030 Clinical Trial.
• Antimicrobial therapy for bronchiectasis.

  O'Donnell AE. O'Donnell AE. Clin Chest Med. 2012 Jun;33(2):381-6. doi: 10.1016/j.ccm.2012.03.005. Epub 2012 Apr 24. Clin Chest Med. 2012. PMID: 22640853 Review.
• The microbiome in bronchiectasis.

  Richardson H, Dicker AJ, Barclay H, Chalmers JD. Richardson H, et al. Eur Respir Rev. 2019 Sep 4;28(153):190048. doi: 10.1183/16000617.0048-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31484665 Free PMC article. Review.